Virbac has launched Stelfonta, a novel injectable solution to treat mastocytoma in dogs.

Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging¹) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or…

Paragon Veterinary Referrals in Yorkshire, has installed a £12,000 Envair CytoFAST Elite cytotoxic safety cabinet to shield its oncology team from exposure to cytotoxic drugs.

The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist…

Virbac is hosting two complimentary ‘Seeing is Believing’ CPD webinars alongside the launch of Stelfonta, its new injectable treatment for mast cell tumours in dogs. 

On Tuesday 8^th September Dr Owen Davies, an RCVS and American Specialist in…

Virbac, the maker of Stelfonta, the new intratumoural treatment for mast cell tumours in dogs, has launched three free interactive online CPD modules.

The modules, which are presented by US veterinary oncology specialists Dr Chad Johannes and Dr Sue Ettinger…

Virbac has launched a toolkit to help veterinary practices educate pet owners about the importance of checking their pet for abnormal lumps and bumps. 

The toolkit contains everything a practice needs to create its own lumps and bumps awareness campaign…

CVS has announced plans for a new multi-disciplinary veterinary referral hospital in Bristol, called Bristol Vet Specialists.

CVS says the new hospital, which will be based at Central Park, Avonmouth, will be custom-built with uniquely designed facilities…

BBraun Vetcare is hosting a Confident Chemotherapy webinar covering the latest thinking on the use of chemotherapy in practice on Thursday 15th July at 5:00pm. 

Presenters at the webinar will include: Professor Melissa McDermid MD, MPH, division head…

Neil Palmer BVSc, MSc (Clin Onc), MRCVS and Kirsty Chippendale, Dip AVN, RVN have launched Cancer Care for Pets, an oncology referral service based out of Donaldson's Veterinary Group Hospital in Huddersfield.

Cancer Care for Pets offers both clinical…

Virbac, manufacturer of Stelfonta, has announced that it will host a series of free webinars on the diagnosis of canine mast cell tumours, in collaboration with BattLab/Laboklin.

The webinars will be presented by specialists in their respective fields;…

The Journal of Small Animal Practice (JSAP) has published a new study which it says supports the use of weekly proteinuria monitoring during the first month of masitinib treatment for neoplasia.

The study, titled “Development and progression of proteinuria…

Yorkshire-based Paragon Referrals has launched a superficial radiation therapy (SRT) service for pets, the first of its kind in the country. 

The service uses an Xstrahl 100 superficial radiotherapy system, a £150,000 piece of equipment installed by Paragon…

Hertfordshire-based Davies Veterinary Specialists has expanded its oncology service with the appointment of American Specialist in Veterinary Oncology, Sarah Benjamin.

This brings the total number of oncology specialists to four, within a service comprising…

Viennese biotech company BlueSky Immunotherapies says it has used its viral vector platform delNS to treat sarcoids in horses successfully, paving the way for a new cancer therapy in humans.

BlueSky says that conventional treatment for equine sarcoids…

Virbac, maker of Stelfonta, has released the result of a quick poll of vets at the London Vet Show who said that on average, they had diagnosed 7.03 mast cell tumours (MCTs) in the last year, when earlier research had showed the figure should be more…

The World Small Animal Veterinary Association Oncology Working Group has published a glossary of common veterinary oncology terms to help owners better understand cancer terminology,

The Oncology Working Group, winningly styled as 'WOW', says it hopes that…

Virbac, maker of Stelfonta, the intratumoural solution to treat mast cell tumours in dogs, is hosting a livestream interactive talk with guest speaker Dr Gerry Polton (RCVS & European Specialist in Veterinary Oncology) on 17th May at 8:00pm.

Virbac points…

A study published in the latest issue of the Journal of Small Animal Practice (JSAP) has found that lymphadenectomy, along with the resection of the primary tumour and adjuvant medical treatment, improves outcome for dogs with Kiupel high-grade cutaneous…

VetSurgeon.org, in partnership with Improve International, is inviting all vets to come and join in this year’s first online Clinical Article Club discussion: 'Diagnosis and treatment of common canine oral tumours'.

For those new to the…

Southfields Veterinary Specialists in Basildon has opened a new oncology and radiotherapy suite.

The new suite offers chemotherapy and radiotherapy treatment facilities under one roof, including a linear accelerator (LINAC) which enables treatment of tumours…

HT Vista has published the results of a small survey which indicates that vets who have been qualified for more than five years are 14% less likely to rely on palpation alone than clinicians with less than five year's experience, when diagnosing lipoma…

Hill's Global Symposium, this year focusing on veterinary oncology and nutrition, is coming up on Monday and Tuesday (25th-26th) next week, online and in Lisbon.

There will be 20 presentations from some of the world's leading experts, covering topics…

CVS Group is installing a state-of-the-art linear accelerator at Bristol Vet Specialists, where it will allow the referral hospital to offer advanced image-guided radiation treatments for cancer in cats and dogs.

The company says the Elekta Infinity…

HT Vista, which makes a device which uses thermal imaging and AI to screen dermal and subcutaneous masses in dogs, has developed a data collection app for use alongside the device.

The app allows practices to submit results along with cytology and histopathology…

HT Vista will be offering a prize of one free HT Vista cancer screening device, plus a year's subscription, to one BSAVA delegate this year.

The HT Vista device is used by vets and vet nurses to screen dermal and subcutaneous masses on dogs. 

The company…

Bristol Vet Specialists, the £13.5M referral centre based to the north west of the city, reports that it has treated its 100th cancer patient with it's state-of-the-art, £1.7M linear accelerator, 12 months after opening.

The Elekta Infinity…